Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.48
+0.05 (0.78%)
At close: Jun 12, 2026, 4:00 PM EDT
6.65
+0.17 (2.62%)
Pre-market: Jun 15, 2026, 5:00 AM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $400.15 million as of June 15, 2026. Its market cap has increased by 255.11% in one year.
Market Cap
400.15M
Enterprise Value
295.65M
1-Year Change
255.11%
Ranking
Category
Stock Price
$6.48
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $400.15M, an increase of 12.78%. That is a compound annual growth rate of 4.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 400.15M | 107.84% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 415.18M |
| Artiva Biotherapeutics | 414.94M |
| Adlai Nortye | 413.20M |
| Ocugen | 409.61M |
| Century Therapeutics | 405.80M |
| Indaptus Therapeutics | 405.41M |
| vTv Therapeutics | 402.56M |
| Monopar Therapeutics | 399.18M |